In the training cohort, maximum tumor diameter, tumor margin, arterial peritumoral enhancement, tumor number, hemoglobin, total bilirubin, direct bilirubin, and AFP were predictive clinical and imaging variables for the presence of MVI in HCC patients (p < 0.05) (Table 2). This evidence concerns the gene AFP and hepatocellular carcinoma.